The global market for Monoclonal Antibodies was valued at US$ 115570 million in the year 2024 and is projected to reach a revised size of US$ 156190 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Monoclonal Antibodies Market

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.

This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibodies.

The Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Monoclonal Antibodies Market Report

Report Metric	Details
Report Name	Monoclonal Antibodies Market
Accounted market size in year	US$ 115570 million
Forecasted market size in 2031	US$ 156190 million
CAGR	4.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Erythropoietin (EPO) Human Growth Hormone (HGH) Granulocyte- Colony Stimulating Factor (G-CSF) Monoclonal Antibody (mAb) Insulin Interferon (IFN) Others
Segment by Application	Anti-Cancer Anti-Inflammatory/Autoimmune
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, 3SBio, Accord Healthcare, AET Biotech, Allergan, Amega Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoclonal Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoclonal Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Monoclonal Antibodies Market growing?

Ans: The Monoclonal Antibodies Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Monoclonal Antibodies Market size in 2031?

Ans: The Monoclonal Antibodies Market size in 2031 will be US$ 156190 million.

Who are the main players in the Monoclonal Antibodies Market report?

Ans: The main players in the Monoclonal Antibodies Market are Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, 3SBio, Accord Healthcare, AET Biotech, Allergan, Amega Biotech

What are the Application segmentation covered in the Monoclonal Antibodies Market report?

Ans: The Applications covered in the Monoclonal Antibodies Market report are Anti-Cancer, Anti-Inflammatory/Autoimmune

What are the Type segmentation covered in the Monoclonal Antibodies Market report?

Ans: The Types covered in the Monoclonal Antibodies Market report are Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte- Colony Stimulating Factor (G-CSF), Monoclonal Antibody (mAb), Insulin, Interferon (IFN), Others

1 Monoclonal Antibodies Market Overview

1.1 Product Definition

1.2 Monoclonal Antibodies by Type

1.2.1 Global Monoclonal Antibodies Market Value Comparison by Type (2024 VS 2031)

1.2.2 Erythropoietin (EPO)

1.2.3 Human Growth Hormone (HGH)

1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)

1.2.5 Monoclonal Antibody (mAb)

1.2.6 Insulin

1.2.7 Interferon (IFN)

1.2.8 Others

1.3 Monoclonal Antibodies by Application

1.3.1 Global Monoclonal Antibodies Market Value by Application (2024 VS 2031)

1.3.2 Anti-Cancer

1.3.3 Anti-Inflammatory/Autoimmune

1.4 Global Monoclonal Antibodies Market Size Estimates and Forecasts

1.4.1 Global Monoclonal Antibodies Revenue 2020-2031

1.4.2 Global Monoclonal Antibodies Sales 2020-2031

1.4.3 Global Monoclonal Antibodies Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Monoclonal Antibodies Market Competition by Manufacturers

2.1 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2020-2025)

2.2 Global Monoclonal Antibodies Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Monoclonal Antibodies Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Monoclonal Antibodies, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Monoclonal Antibodies, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Monoclonal Antibodies, Product Type & Application

2.7 Global Key Manufacturers of Monoclonal Antibodies, Date of Enter into This Industry

2.8 Global Monoclonal Antibodies Market Competitive Situation and Trends

2.8.1 Global Monoclonal Antibodies Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Monoclonal Antibodies Players Market Share by Revenue

2.8.3 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Monoclonal Antibodies Market Scenario by Region

3.1 Global Monoclonal Antibodies Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Monoclonal Antibodies Sales by Region: 2020-2031

3.2.1 Global Monoclonal Antibodies Sales by Region: 2020-2025

3.2.2 Global Monoclonal Antibodies Sales by Region: 2026-2031

3.3 Global Monoclonal Antibodies Revenue by Region: 2020-2031

3.3.1 Global Monoclonal Antibodies Revenue by Region: 2020-2025

3.3.2 Global Monoclonal Antibodies Revenue by Region: 2026-2031

3.4 North America Monoclonal Antibodies Market Facts & Figures by Country

3.4.1 North America Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Monoclonal Antibodies Sales by Country (2020-2031)

3.4.3 North America Monoclonal Antibodies Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Monoclonal Antibodies Market Facts & Figures by Country

3.5.1 Europe Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Monoclonal Antibodies Sales by Country (2020-2031)

3.5.3 Europe Monoclonal Antibodies Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Monoclonal Antibodies Market Facts & Figures by Region

3.6.1 Asia Pacific Monoclonal Antibodies Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Monoclonal Antibodies Sales by Region (2020-2031)

3.6.3 Asia Pacific Monoclonal Antibodies Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Monoclonal Antibodies Market Facts & Figures by Country

3.7.1 Latin America Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Monoclonal Antibodies Sales by Country (2020-2031)

3.7.3 Latin America Monoclonal Antibodies Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Monoclonal Antibodies Market Facts & Figures by Country

3.8.1 Middle East and Africa Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Monoclonal Antibodies Sales by Country (2020-2031)

3.8.3 Middle East and Africa Monoclonal Antibodies Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Monoclonal Antibodies Sales by Type (2020-2031)

4.1.1 Global Monoclonal Antibodies Sales by Type (2020-2025)

4.1.2 Global Monoclonal Antibodies Sales by Type (2026-2031)

4.1.3 Global Monoclonal Antibodies Sales Market Share by Type (2020-2031)

4.2 Global Monoclonal Antibodies Revenue by Type (2020-2031)

4.2.1 Global Monoclonal Antibodies Revenue by Type (2020-2025)

4.2.2 Global Monoclonal Antibodies Revenue by Type (2026-2031)

4.2.3 Global Monoclonal Antibodies Revenue Market Share by Type (2020-2031)

4.3 Global Monoclonal Antibodies Price by Type (2020-2031)

5 Segment by Application

5.1 Global Monoclonal Antibodies Sales by Application (2020-2031)

5.1.1 Global Monoclonal Antibodies Sales by Application (2020-2025)

5.1.2 Global Monoclonal Antibodies Sales by Application (2026-2031)

5.1.3 Global Monoclonal Antibodies Sales Market Share by Application (2020-2031)

5.2 Global Monoclonal Antibodies Revenue by Application (2020-2031)

5.2.1 Global Monoclonal Antibodies Revenue by Application (2020-2025)

5.2.2 Global Monoclonal Antibodies Revenue by Application (2026-2031)

5.2.3 Global Monoclonal Antibodies Revenue Market Share by Application (2020-2031)

5.3 Global Monoclonal Antibodies Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Biocon

6.1.1 Biocon Company Information

6.1.2 Biocon Description and Business Overview

6.1.3 Biocon Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Biocon Monoclonal Antibodies Product Portfolio

6.1.5 Biocon Recent Developments/Updates

6.2 Celltrion

6.2.1 Celltrion Company Information

6.2.2 Celltrion Description and Business Overview

6.2.3 Celltrion Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Celltrion Monoclonal Antibodies Product Portfolio

6.2.5 Celltrion Recent Developments/Updates

6.3 Dr. Reddy's Laboratories

6.3.1 Dr. Reddy's Laboratories Company Information

6.3.2 Dr. Reddy's Laboratories Description and Business Overview

6.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Product Portfolio

6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates

6.4 Hospira

6.4.1 Hospira Company Information

6.4.2 Hospira Description and Business Overview

6.4.3 Hospira Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Hospira Monoclonal Antibodies Product Portfolio

6.4.5 Hospira Recent Developments/Updates

6.5 3SBio

6.5.1 3SBio Company Information

6.5.2 3SBio Description and Business Overview

6.5.3 3SBio Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)

6.5.4 3SBio Monoclonal Antibodies Product Portfolio

6.5.5 3SBio Recent Developments/Updates

6.6 Accord Healthcare

6.6.1 Accord Healthcare Company Information

6.6.2 Accord Healthcare Description and Business Overview

6.6.3 Accord Healthcare Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Accord Healthcare Monoclonal Antibodies Product Portfolio

6.6.5 Accord Healthcare Recent Developments/Updates

6.7 AET Biotech

6.7.1 AET Biotech Company Information

6.7.2 AET Biotech Description and Business Overview

6.7.3 AET Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)

6.7.4 AET Biotech Monoclonal Antibodies Product Portfolio

6.7.5 AET Biotech Recent Developments/Updates

6.8 Allergan

6.8.1 Allergan Company Information

6.8.2 Allergan Description and Business Overview

6.8.3 Allergan Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Allergan Monoclonal Antibodies Product Portfolio

6.8.5 Allergan Recent Developments/Updates

6.9 Amega Biotech

6.9.1 Amega Biotech Company Information

6.9.2 Amega Biotech Description and Business Overview

6.9.3 Amega Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Amega Biotech Monoclonal Antibodies Product Portfolio

6.9.5 Amega Biotech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Monoclonal Antibodies Industry Chain Analysis

7.2 Monoclonal Antibodies Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Monoclonal Antibodies Production Mode & Process Analysis

7.4 Monoclonal Antibodies Sales and Marketing

7.4.1 Monoclonal Antibodies Sales Channels

7.4.2 Monoclonal Antibodies Distributors

7.5 Monoclonal Antibodies Customer Analysis

8 Monoclonal Antibodies Market Dynamics

8.1 Monoclonal Antibodies Industry Trends

8.2 Monoclonal Antibodies Market Drivers

8.3 Monoclonal Antibodies Market Challenges

8.4 Monoclonal Antibodies Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Biocon Ltd.

Celltrion

Dr. Reddy’s Laboratories

List of Tables

Table 1. Global Monoclonal Antibodies Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Monoclonal Antibodies Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2024

Table 4. Global Monoclonal Antibodies Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Monoclonal Antibodies Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Monoclonal Antibodies Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Monoclonal Antibodies, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Monoclonal Antibodies, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Monoclonal Antibodies, Product Type & Application

Table 12. Global Key Manufacturers of Monoclonal Antibodies, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Monoclonal Antibodies Sales by Region (2020-2025) & (Units)

Table 18. Global Monoclonal Antibodies Sales Market Share by Region (2020-2025)

Table 19. Global Monoclonal Antibodies Sales by Region (2026-2031) & (Units)

Table 20. Global Monoclonal Antibodies Sales Market Share by Region (2026-2031)

Table 21. Global Monoclonal Antibodies Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Monoclonal Antibodies Revenue Market Share by Region (2020-2025)

Table 23. Global Monoclonal Antibodies Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Monoclonal Antibodies Revenue Market Share by Region (2026-2031)

Table 25. North America Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Monoclonal Antibodies Sales by Country (2020-2025) & (Units)

Table 27. North America Monoclonal Antibodies Sales by Country (2026-2031) & (Units)

Table 28. North America Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Monoclonal Antibodies Sales by Country (2020-2025) & (Units)

Table 32. Europe Monoclonal Antibodies Sales by Country (2026-2031) & (Units)

Table 33. Europe Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Monoclonal Antibodies Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Monoclonal Antibodies Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Monoclonal Antibodies Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Monoclonal Antibodies Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Monoclonal Antibodies Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Monoclonal Antibodies Sales by Country (2020-2025) & (Units)

Table 42. Latin America Monoclonal Antibodies Sales by Country (2026-2031) & (Units)

Table 43. Latin America Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Monoclonal Antibodies Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Monoclonal Antibodies Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Monoclonal Antibodies Sales (Units) by Type (2020-2025)

Table 51. Global Monoclonal Antibodies Sales (Units) by Type (2026-2031)

Table 52. Global Monoclonal Antibodies Sales Market Share by Type (2020-2025)

Table 53. Global Monoclonal Antibodies Sales Market Share by Type (2026-2031)

Table 54. Global Monoclonal Antibodies Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Monoclonal Antibodies Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Monoclonal Antibodies Revenue Market Share by Type (2020-2025)

Table 57. Global Monoclonal Antibodies Revenue Market Share by Type (2026-2031)

Table 58. Global Monoclonal Antibodies Price (USD/Unit) by Type (2020-2025)

Table 59. Global Monoclonal Antibodies Price (USD/Unit) by Type (2026-2031)

Table 60. Global Monoclonal Antibodies Sales (Units) by Application (2020-2025)

Table 61. Global Monoclonal Antibodies Sales (Units) by Application (2026-2031)

Table 62. Global Monoclonal Antibodies Sales Market Share by Application (2020-2025)

Table 63. Global Monoclonal Antibodies Sales Market Share by Application (2026-2031)

Table 64. Global Monoclonal Antibodies Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Monoclonal Antibodies Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Monoclonal Antibodies Revenue Market Share by Application (2020-2025)

Table 67. Global Monoclonal Antibodies Revenue Market Share by Application (2026-2031)

Table 68. Global Monoclonal Antibodies Price (USD/Unit) by Application (2020-2025)

Table 69. Global Monoclonal Antibodies Price (USD/Unit) by Application (2026-2031)

Table 70. Biocon Company Information

Table 71. Biocon Description and Business Overview

Table 72. Biocon Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Biocon Monoclonal Antibodies Product

Table 74. Biocon Recent Developments/Updates

Table 75. Celltrion Company Information

Table 76. Celltrion Description and Business Overview

Table 77. Celltrion Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Celltrion Monoclonal Antibodies Product

Table 79. Celltrion Recent Developments/Updates

Table 80. Dr. Reddy's Laboratories Company Information

Table 81. Dr. Reddy's Laboratories Description and Business Overview

Table 82. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Dr. Reddy's Laboratories Monoclonal Antibodies Product

Table 84. Dr. Reddy's Laboratories Recent Developments/Updates

Table 85. Hospira Company Information

Table 86. Hospira Description and Business Overview

Table 87. Hospira Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Hospira Monoclonal Antibodies Product

Table 89. Hospira Recent Developments/Updates

Table 90. 3SBio Company Information

Table 91. 3SBio Description and Business Overview

Table 92. 3SBio Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. 3SBio Monoclonal Antibodies Product

Table 94. 3SBio Recent Developments/Updates

Table 95. Accord Healthcare Company Information

Table 96. Accord Healthcare Description and Business Overview

Table 97. Accord Healthcare Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Accord Healthcare Monoclonal Antibodies Product

Table 99. Accord Healthcare Recent Developments/Updates

Table 100. AET Biotech Company Information

Table 101. AET Biotech Description and Business Overview

Table 102. AET Biotech Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. AET Biotech Monoclonal Antibodies Product

Table 104. AET Biotech Recent Developments/Updates

Table 105. Allergan Company Information

Table 106. Allergan Description and Business Overview

Table 107. Allergan Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Allergan Monoclonal Antibodies Product

Table 109. Allergan Recent Developments/Updates

Table 110. Amega Biotech Company Information

Table 111. Amega Biotech Description and Business Overview

Table 112. Amega Biotech Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Amega Biotech Monoclonal Antibodies Product

Table 114. Amega Biotech Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Monoclonal Antibodies Distributors List

Table 118. Monoclonal Antibodies Customers List

Table 119. Monoclonal Antibodies Market Trends

Table 120. Monoclonal Antibodies Market Drivers

Table 121. Monoclonal Antibodies Market Challenges

Table 122. Monoclonal Antibodies Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Monoclonal Antibodies

Figure 2. Global Monoclonal Antibodies Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Monoclonal Antibodies Market Share by Type: 2024 & 2031

Figure 4. Erythropoietin (EPO) Product Picture

Figure 5. Human Growth Hormone (HGH) Product Picture

Figure 6. Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture

Figure 7. Monoclonal Antibody (mAb) Product Picture

Figure 8. Insulin Product Picture

Figure 9. Interferon (IFN) Product Picture

Figure 10. Others Product Picture

Figure 11. Global Monoclonal Antibodies Market Value by Application (2020-2031) & (US$ Million)

Figure 12. Global Monoclonal Antibodies Market Share by Application: 2024 & 2031

Figure 13. Anti-Cancer

Figure 14. Anti-Inflammatory/Autoimmune

Figure 15. Global Monoclonal Antibodies Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Monoclonal Antibodies Market Size (2020-2031) & (US$ Million)

Figure 17. Global Monoclonal Antibodies Sales (2020-2031) & (Units)

Figure 18. Global Monoclonal Antibodies Average Price (USD/Unit) & (2020-2031)

Figure 19. Monoclonal Antibodies Report Years Considered

Figure 20. Monoclonal Antibodies Sales Share by Manufacturers in 2024

Figure 21. Global Monoclonal Antibodies Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Monoclonal Antibodies Players: Market Share by Revenue in Monoclonal Antibodies in 2024

Figure 23. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Monoclonal Antibodies Sales Market Share by Country (2020-2031)

Figure 26. North America Monoclonal Antibodies Revenue Market Share by Country (2020-2031)

Figure 27. U.S. Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Monoclonal Antibodies Sales Market Share by Country (2020-2031)

Figure 30. Europe Monoclonal Antibodies Revenue Market Share by Country (2020-2031)

Figure 31. Germany Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Monoclonal Antibodies Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Monoclonal Antibodies Revenue Market Share by Region (2020-2031)

Figure 38. China Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Taiwan Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Philippines Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Monoclonal Antibodies Sales Market Share by Country (2020-2031)

Figure 49. Latin America Monoclonal Antibodies Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Monoclonal Antibodies Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. U.A.E Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Monoclonal Antibodies by Type (2020-2031)

Figure 59. Global Revenue Market Share of Monoclonal Antibodies by Type (2020-2031)

Figure 60. Global Monoclonal Antibodies Price (USD/Unit) by Type (2020-2031)

Figure 61. Global Sales Market Share of Monoclonal Antibodies by Application (2020-2031)

Figure 62. Global Revenue Market Share of Monoclonal Antibodies by Application (2020-2031)

Figure 63. Global Monoclonal Antibodies Price (USD/Unit) by Application (2020-2031)

Figure 64. Monoclonal Antibodies Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions